Evidence map›Paper›PMID 34127764›Full record

ArticleCommunications biology2021

Albumin in patients with liver disease shows an altered conformation.

Margret Paar, Vera H Fengler, Daniel J Rosenberg, Angelika Krebs, Rudolf E Stauber, Karl Oettl, Michal Hammel

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Modulation of Albumin Esterase Activity by Warfarin and Diazepam.International journal of molecular sciences · 2024
    Article
  7. Article
  8. [Research progress on detection techniques for effective albumin concentration].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Review
  9. Review
  10. Binding and detoxification efficiency of albumin decline after haemodialysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Evolving Experimental Techniques for Structure-Based Drug Design.The journal of physical chemistry. B · 2022
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Margret Paar *Division of Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.
Vera H Fengler *Division of Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria.
Daniel J RosenbergMolecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Angelika KrebsScience Technology Interface-Structural Biology, Center for Medical Research, Medical University of Graz, Graz, Austria.
Rudolf E StauberDepartment of Internal Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0002-3687-9331
Karl OettlDivision of Physiological Chemistry, Otto-Loewi Research Center, Medical University of Graz, Graz, Austria. karl.oettl@medunigraz.at.ORCID 0000-0001-9792-5760
Michal HammelMolecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA. mhammel@lbl.gov.ORCID 0000-0002-5610-9289
Medical University of Graz · ATLawrence Berkeley National Laboratory · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WALTER J. CHAZIN · 2001 to 2026
$89.6M
User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
NCI NIH HHS P01 CA092584NIGMS NIH HHS P30 GM124169
6 · The paper itself

Abstract

Human serum albumin (HSA) constitutes the primary transporter of fatty acids, bilirubin, and other plasma compounds. The binding, transport, and release of its cargos strongly depend on albumin conformation, which is affected by bound ligands induced by physiological and pathological conditions. HSA is both highly oxidized and heavily loaded with fatty acids and bilirubin in chronic liver disease. By employing small-angle X-ray scattering we show that HSA from the plasma of chronic liver disease patients undergoes a distinct opening compared to healthy donors. The extent of HSA opening correlates with clinically relevant variables, such as the model of end-stage liver disease score, bilirubin, and fatty acid levels. Although the mild oxidation of HSA in vitro does not alter overall structure, the alteration of patients' HSA correlates with its redox state. This study connects clinical data with structural visualization of albumin dynamicity in solution and underlines the functional importance of albumin's inherent flexibility.

Indexed as

AdultAgedAged, 80 and overBilirubinCase-Control StudiesEnd Stage Liver DiseaseFatty AcidsHumansLiver DiseasesMaleMiddle AgedOxidation-ReductionProtein Structure, TertiarySerum AlbuminYoung AdultBilirubinFatty AcidsSerum Albumin

Identifiers

PMID34127764
PMCPMC8203801
OpenAlexW3173075894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.